Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 trial of AZD8931 plus anastrozole vs anastrozole alone in postmenopausal women with hormone receptor–positive advanced breast cancer
jRCT2080221559Phase 2
- Sponsor
- AstraZeneca
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sapitinib in breast cancer (3 arms), sponsored by AstraZeneca.
02
Drugs
sapitinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on jRCT2080221559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221559.